Literature DB >> 8556512

Human antibody response to the B oligomer of pertussis toxin.

F Lynn1, W N Burnette, G R Siber, J L Arciniega.   

Abstract

To determine whether antibodies to the B oligomer of pertussis toxin (PT) were present in patients diagnosed with pertussis or vaccinees who had received diphtheria-tetanus-whole-cell pertussis vaccine, we analyzed serum samples from 5 patients and 10 vaccinees by both enzyme-linked immunosorbent assay (ELISA) and Western immunoblotting techniques. Antibodies to the B oligomer were detected by ELISA in all samples containing antibodies to holotoxin. Western immunoblotting procedures were less efficient than ELISA techniques for detecting antibodies to the B oligomer. Antibodies which inhibit the ability of the B oligomer to agglutinate erythrocytes were detected in purified human immunoglobulin preparations. In addition, serum samples containing antibodies to PT inhibited the binding of purified B oligomer and holotoxin to a 165-kDa glycoprotein which has been considered a potential PT receptor in Chinese hamster ovary (CHO) cells. These results suggest that antibodies to the B oligomer contribute to the human serologic response to PT, but their detection and characterization require appropriate methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556512      PMCID: PMC368377          DOI: 10.1128/cdli.1.6.626-632.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology.

Authors:  D L Burns; J G Kenimer; C R Manclark
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

2.  Immune response to the B oligomer of pertussis toxin.

Authors:  J L Arciniega; D L Burns; E Garcia-Ortigoza; C R Manclark
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Structural characterization of pertussis toxin A subunit.

Authors:  D L Burns; S Z Hausman; W Lindner; F A Robey; C R Manclark
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

4.  Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.

Authors:  P Askelöf; P Gillenius
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Dual mechanisms involved in development of diverse biological activities of islet-activating protein, pertussis toxin, as revealed by chemical modification of lysine residues in the toxin molecule.

Authors:  K Nogimori; M Tamura; M Yajima; K Ito; T Nakamura; N Kajikawa; Y Maruyama; M Ui
Journal:  Biochim Biophys Acta       Date:  1984-09-28

8.  Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.

Authors:  H Sato; A Ito; J Chiba; Y Sato
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Tamura; M Ui
Journal:  Arch Biochem Biophys       Date:  1983-07-01       Impact factor: 4.013

10.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.